Latest / Conquer Your Weight / Episode #138: Will Hormone Replacement Therapy Help You Lose Weight?
Transcript
- 0:00Dr. Sarah Stombaugh: This is Dr.
- 0:00Dr. Sarah Stombaugh: Sarah Stambaugh, and you are listening to the Conquer Your Weight Podcast.
- 0:09Announcer: Welcome to the Conquer Your Weight Podcast, where you will learn to understand your mind and body so you can achieve long-term weight loss.
- 0:16Announcer: Here's your host, obesity medicine physician and life coach, Dr.
- 0:21Announcer: Sarah Stambaugh.
- 0:29Dr. Sarah Stombaugh: Hello, everyone, and welcome to this week's episode of the Conquer Your Weight podcast.
- 0:34Dr. Sarah Stombaugh: We are talking about a so, so important topic, which is hormone replacement therapy.
- 0:40Dr. Sarah Stombaugh: And can hormone replacement therapy have an impact on weight, on weight loss goals?
- 0:47Dr. Sarah Stombaugh: And this is a very controversial topic.
- 0:50Dr. Sarah Stombaugh: We today are going to dive into what are the sex hormones, estrogen, progesterone, testosterone, what roles do those have in our body in general?
- 1:00Dr. Sarah Stombaugh: How do those change during perimenopausal and menopausal years?
- 1:04Dr. Sarah Stombaugh: And then especially if you've been dealing with perimenopausal, postmenopausal weight gain, what, if any, is the role of hormone replacement therapy in supporting your health and weight goals?
- 1:17Dr. Sarah Stombaugh: This is a topic that I think we could talk about probably for 10 hours, so I'm going to do my best to talk about it in a single episode and to give you some of the great data you need.
- 1:28Dr. Sarah Stombaugh: What is absolutely going to be true is that this is going to be ongoing.
- 1:33Dr. Sarah Stombaugh: I think we'll likely have some updates to this as well as maybe a part two coming down sometime down the road, either just myself again, or perhaps bringing in a guest speaker in this area, because this is a conversation that amazingly has been happening more and more, recognizing that very commonly women are gaining weight in their perimenopausal and postmenopausal years.
- 1:58Dr. Sarah Stombaugh: And they're frustrated and they're fed up with it.
- 2:02Dr. Sarah Stombaugh: And let's talk about this.
- 2:04Dr. Sarah Stombaugh: How can we support them?
- 2:07Dr. Sarah Stombaugh: So let's take a step back and look at what are the sex hormones?
- 2:12Dr. Sarah Stombaugh: What are the roles that those play in our body?
- 2:15Dr. Sarah Stombaugh: And you know, does decreasing those, does increasing those, how can we, how do those impact our health?
- 2:21Dr. Sarah Stombaugh: So today we're going to be talking about the role of estrogen, progesterone, and testosterone, but we're primarily actually going to be focusing on the estrogen piece.
- 2:32Dr. Sarah Stombaugh: So when we think about all of these hormones, the estrogen, progesterone, testosterone, a lot of times we think of estrogen and progesterone as woman's hormones and testosterone as man's hormones.
- 2:44Dr. Sarah Stombaugh: But the reality is Women also have testosterone.
- 2:48Dr. Sarah Stombaugh: Men also have estrogen.
- 2:49Dr. Sarah Stombaugh: And so both genders, both sexes do have these hormones naturally.
- 2:56Dr. Sarah Stombaugh: Now for all women, there's estrogen, there's progesterone, and there's testosterone, and all of these levels decrease during the perimenopausal and postmenopausal years.
- 3:06Dr. Sarah Stombaugh: During perimenopausal years, there's often this sort of crazy up and down rollercoaster that happens.
- 3:12Dr. Sarah Stombaugh: So sometimes those levels are surging, sometimes they're dropping back through the floor, and those rapid changes in hormones day over day or week over week can create some of the really big challenges in terms of major menopause and perimenopausal symptoms.
- 3:28Dr. Sarah Stombaugh: So estrogen, like I said, we think about it in the context of our sex hormones.
- 3:35Dr. Sarah Stombaugh: We think about it in helping us to perhaps ovulate or to get pregnant or to have a baby and the roles that it may play in our menstruation cycle month over month with the goal of thinking about from a fertility standpoint.
- 3:49Dr. Sarah Stombaugh: But the reality is estrogen does so, so much more than that.
- 3:53Dr. Sarah Stombaugh: Estrogen signals throughout the entire human body their There are over 3,600 estrogen receptors in the human body, and we know that it plays a really significant role in things like our cardiovascular health.
- 4:07Dr. Sarah Stombaugh: So having estrogen in our body helps to reduce the risk of cardiovascular disease.
- 4:12Dr. Sarah Stombaugh: plays a really significant role in bone health.
- 4:15Dr. Sarah Stombaugh: So certainly decreasing bone density with things like osteopenia or osteoporosis become much more common in later years of life for other reasons as well.
- 4:28Dr. Sarah Stombaugh: But this estrogen deficiency can be one of the main reasons that happens.
- 4:32Dr. Sarah Stombaugh: It plays a role in our metabolic health.
- 4:34Dr. Sarah Stombaugh: And so this is related to the weight gain that we often see in the peri and postmenopausal years.
- 4:41Dr. Sarah Stombaugh: And it's not just weight gain it's an insulin resistance that can lead crease lead to not just weight gain but actually visceral adiposity so when we think about that central weight gain we think about weight that comes on that sort of tire or softness that happens in the abdomen a lot of times people think about the weight that's sitting on the sort of on the outside the subcutaneous fat subcutaneous fat is the fat that you can pinch it's fat that you could grab with your hands it might be kind of jiggly where a visceral adiposity is a fat tissue that accumulates in and around our organs.
- 5:18Dr. Sarah Stombaugh: Now, While subcutaneous fat may not be desirable for someone, they may still wish to lose that weight as well.
- 5:26Dr. Sarah Stombaugh: It's not necessarily dangerous, doesn't come with increased metabolic health disease risk, where visceral adiposity, that fat that is in and around our tissues, does have an increased risk of cardiometabolic disease.
- 5:40Dr. Sarah Stombaugh: And so this is why sometimes we'll notice, even if there's not that soft, loose or grabbable fat on the outside of the body, there still may be an increasing waist circumference.
- 5:53Dr. Sarah Stombaugh: A very classic example, if you think of sort of the middle-aged or a middle-aged man who maybe has skinny arms and legs, but just has a large belly, but it looks kind of taut.
- 6:06Dr. Sarah Stombaugh: It's this firm, large belly.
- 6:07Dr. Sarah Stombaugh: While that can be associated with certain alcohol conditions, for example, it can also be associated with metabolic health.
- 6:14Dr. Sarah Stombaugh: And so that taut abdomen, there's not necessarily fat that you could grab.
- 6:19Dr. Sarah Stombaugh: It's not just but it's that visceral adiposity, the fat tissue that accumulates in and around our organs.
- 6:26Dr. Sarah Stombaugh: And this is the type of fat tissue that is very metabolically dangerous and can increase the risk of heart attacks, of strokes, can increase the risk of other metabolic diseases like type two diabetes.
- 6:40Dr. Sarah Stombaugh: And so this is the type of fat that during peri and postmenopausal years, we may experience both of those, a both subcutaneous fat that sort of saw or looser fat as well as that visceral adiposity, but it's that visceral fat that is most dangerous.
- 6:57Dr. Sarah Stombaugh: And both of these can increase during the period and post-menopausal years because of decrease in estrogen.
- 7:02Dr. Sarah Stombaugh: We also know that we have estrogen receptors in our brain.
- 7:06Dr. Sarah Stombaugh: And so when it comes to risk of dementia, for example, the decreasing estrogen receptors and decreasing estrogen stimulation on those receptors increases the risk of dementia, for example.
- 7:17Dr. Sarah Stombaugh: And those are just a few specific call outs, you know, certainly in terms of things like the vulvar tissue, the vaginal tissue can get more dry, which can increase risk of urinary tract infections.
- 7:30Dr. Sarah Stombaugh: And so estrogen plays many, many more roles even beyond these, but that cardiovascular health the risk of osteoporosis, the metabolic health, the brain health, the urogenital system health, all of these things are very directly tied to estrogen.
- 7:47Dr. Sarah Stombaugh: And what very commonly happens is that when we look at women's health in their perimenopausal years where their estrogen is going crazy, and then in their postmenopausal years where that estrogen level is reaching lower levels, we start to see a significant increased risk of many of these different conditions.
- 8:06Dr. Sarah Stombaugh: What I very commonly see for women is in terms of metabolic health and weight gain, for example, is they have gone their whole life through their 30s, maybe even their early 40s, and weight has been pretty stable.
- 8:20Dr. Sarah Stombaugh: They know their body, they know their routine, they know that if they eat a certain way and they move a certain way that their body will stay at a stable weight.
- 8:28Dr. Sarah Stombaugh: And then all of a sudden that changes in a drastic and frustrating way because they're doing the exact same thing, yet they're starting to accumulate weight around their body.
- 8:36Dr. Sarah Stombaugh: around their midsection.
- 8:38Dr. Sarah Stombaugh: And a lot of times starting to see lab changes as well.
- 8:41Dr. Sarah Stombaugh: We'll see a lot of times increase in cholesterol levels.
- 8:45Dr. Sarah Stombaugh: We'll see increase in blood pressure.
- 8:46Dr. Sarah Stombaugh: We'll see increase in blood sugar levels and a hemoglobin A1C.
- 8:51Dr. Sarah Stombaugh: Both of those things are closely related to one another.
- 8:54Dr. Sarah Stombaugh: Women may have gone from having fasting blood sugar levels in the seventies or eighties, and now they're seeing levels in the nineties or the low one hundreds kind of flagging either just barely above the normal range or in that at the very high end of the normal range.
- 9:09Dr. Sarah Stombaugh: Similarly, their hemoglobin A1c that looks at the blood sugar over three months period of time.
- 9:14Dr. Sarah Stombaugh: may have lived in the 5.3, 5.4 range and been totally stable there.
- 9:20Dr. Sarah Stombaugh: And now as they've gone through menopause, they see that level 5.6, 5.7, 5.8, or even higher.
- 9:27Dr. Sarah Stombaugh: We know that the risk of insulin resistance with decreasing estrogen levels is significant and the risk of type two diabetes can certainly come up.
- 9:36Dr. Sarah Stombaugh: And so these changes are frustrating.
- 9:39Dr. Sarah Stombaugh: From a weight perspective, we see it generally pretty, obviously we see it pretty quickly, But some of those other changes with cardiovascular disease, with bone health, with brain health, with all of these other pieces, a lot of times those are just sort of simmering underneath the surface and may not be apparent till many years later.
- 9:59Dr. Sarah Stombaugh: Now, one of the biggest challenges is there's been this big swing in the pendulum of how we view hormone replacement therapy.
- 10:07Dr. Sarah Stombaugh: A few decades ago, we were pretty pro hormone replacement therapy as a society, as a medical community, the women's health and came out in the early 2000s that said, whoa, whoa, whoa, there's a huge increased risk of breast cancer and ovarian cancer and heart disease and blood clots and all of these things just instantaneously and abruptly stopped the use of hormone replacement therapy for many women who were doing just fine on their hormone replacement therapy.
- 10:36Dr. Sarah Stombaugh: And what we've seen is really an entire generation of women who have gone through menopause without the support of hormone replacement therapy or even when they were given it, were given this idea of taking the lowest dose possible for the shortest amount of time possible.
- 10:52Dr. Sarah Stombaugh: And so women for whom maybe did do it begrudgingly, sort of fearfully being afraid of, oh my gosh, how is this increasing my breast cancer risk, for example.
- 11:02Dr. Sarah Stombaugh: And then even if that medication was working really well for them and they felt really good on it, being discontinued on that medication, maybe prematurely or before they wanted to.
- 11:12Dr. Sarah Stombaugh: What will be beyond the scope of Thank you so much for joining us.
- 11:25Dr. Sarah Stombaugh: We as a medical community have been re-evaluating that data.
- 11:34Dr. Sarah Stombaugh: They've looked at subgroup analysis.
- 11:36Dr. Sarah Stombaugh: So if you look at 50-year-old women versus 60-year-old versus 70-year-old versus 80, there's a very different risk based on age, also based on other medical conditions, based on things like family history.
- 11:49Dr. Sarah Stombaugh: And so when they have done subgroup analyses, it has actually shown that, oh, things aren't as bad as we thought.
- 11:56Dr. Sarah Stombaugh: And oops, actually, there may be quite a bit of benefit in hormone replacement therapy.
- 12:01Dr. Sarah Stombaugh: given to the right people at the right stage.
- 12:05Dr. Sarah Stombaugh: What we do know is that when estrogen receptors are not stimulated constantly, that they may downregulate.
- 12:13Dr. Sarah Stombaugh: And this is true for a If the receptor is not being stimulated, that the receptor may not have a need and they may decrease in number.
- 12:25Dr. Sarah Stombaugh: And so what happens with estrogen receptors is that as we go through menopause and those early postmenopausal years where the body is seeing less exposure to estrogen, that it may decrease the number of estrogen receptors such that if a person has been without estrogen stimulation, sort of the general rule of thumb is about a decade, but there's some for specific indications, maybe a little more, a little bit less, that even in giving them hormone replacement therapy, if they haven't had stimulation of those receptors in a while, that giving the hormones may not actually unfortunately do much.
- 13:02Dr. Sarah Stombaugh: And so you can find yourself in a position where even if you're taking hormone replacement therapy for heart health or for bone health or for some of these other conditions, there may not be the same benefit compared to if you had continued estrogen.
- 13:16Dr. Sarah Stombaugh: Now, again, that's sort of a general statement that won't apply to every single health condition.
- 13:21Dr. Sarah Stombaugh: So it's valuable to have that conversation with your own physician.
- 13:25Dr. Sarah Stombaugh: Also, even to read and educate yourself about it.
- 13:29Dr. Sarah Stombaugh: One of my favorite books on the topic is a book called Estrogen Matters by a There's also a podcast recently that my good friend, Dr.
- 13:40Dr. Sarah Stombaugh: Rachel Rubin did with Peter Attia, where they're talking about hormone replacement therapy and safety.
- 13:47Dr. Sarah Stombaugh: And honestly, whether you're a patient or whether you are another provider who is listening to this podcast, those two resources, Estrogen Matters book and the podcast with Dr.
- 13:58Dr. Sarah Stombaugh: Rachel Rubin on Peter Attia, those are really good starting places to see people talk about estrogen in a very evidence-based type way.
- 14:07Dr. Sarah Stombaugh: So that being said, we are going to get into a little bit about what does it mean to use estrogen replacement therapy or hormone replacement therapy, and does that have an impact on our weight?
- 14:22Dr. Sarah Stombaugh: What does the data show?
- 14:23Dr. Sarah Stombaugh: Now, what I will tell you is there's not a lot of data out there.
- 14:27Dr. Sarah Stombaugh: There are certainly many case studies.
- 14:29Dr. Sarah Stombaugh: There's a lot of good retrospective data studies, meaning they look at patient charts, look back at things that have happened, and we're just starting to get some prospective type studies where patients are being randomized to receive either or types of treatments and then looking at what happens.
- 14:47Dr. Sarah Stombaugh: So when we look at using estrogen in weight and how does that actually work?
- 14:55Dr. Sarah Stombaugh: Does that actually help?
- 14:57Dr. Sarah Stombaugh: Here is what we know.
- 14:59Dr. Sarah Stombaugh: So again, I'm speaking about estrogen, but this will be sort of encompassing of estrogen alone versus estrogen with progesterone.
- 15:08Dr. Sarah Stombaugh: What we know is that for women who still have a uterus, so women who have not had a hysterectomy, that they will need some sort of progesterone replacement also to help promote the safety and health of the uterus.
- 15:22Dr. Sarah Stombaugh: We know that giving estrogen by itself without any sort of progesterone will grow and thicken the lining of the uterus.
- 15:29Dr. Sarah Stombaugh: This is part of the normal menstrual cycle.
- 15:32Dr. Sarah Stombaugh: It helps to grow and stimulate the lining of the uterus.
- 15:34Dr. Sarah Stombaugh: And then later in the menstrual cycle, when progesterone levels to Wrap off.
- 15:38Dr. Sarah Stombaugh: and estrogen levels drop off, that we would have a period, a menstrual cycle where all of that would shed.
- 15:45Dr. Sarah Stombaugh: Now, after menopause, there's not going to be any sort of menstrual cycle.
- 15:51Dr. Sarah Stombaugh: And so you want to make sure that someone who still has a uterus does have some sort of progesterone therapy in addition to their estrogen, because we want to make sure to protect the lining of the uterus because thickening the lining of the uterus could increase the risk of endometrial or uterine cancers.
- 16:09Dr. Sarah Stombaugh: So...
- 16:10Dr. Sarah Stombaugh: This is referring to both estrogen and estrogen progesterone.
- 16:14Dr. Sarah Stombaugh: So it'll be dependent on the individual.
- 16:16Dr. Sarah Stombaugh: Progesterone therapy can look like a lot of different things, whether it's progesterone pills, whether it's an IUD, lots of different ways that people may take progesterone.
- 16:24Dr. Sarah Stombaugh: So what we know about the role in estrogen, we talked about how there's this major metabolic effect that happens.
- 16:31Dr. Sarah Stombaugh: And it's very common that this change in metabolic effect changes our fat distribution, may also contribute to muscle loss.
- 16:40Dr. Sarah Stombaugh: And so when we look at body composition and we think about not just what is your weight on the scale, but what is your muscle mass versus what is your fat mass, declining levels of estrogen can contribute to those changes of body composition where we have an increase proportionally of fat mass and a decrease of muscle mass.
- 17:00Dr. Sarah Stombaugh: And so even if the weight on the scale stays the same, a lot of people may notice that the size of their body, the way their clothing fits, for example, is very different compared to before menopause.
- 17:13Dr. Sarah Stombaugh: So estrogen absolutely plays a role with that.
- 17:15Dr. Sarah Stombaugh: For women, an average weight gain...
- 17:17Dr. Sarah Stombaugh: of about one and a half pounds per year attributed to that estrogen decline alone.
- 17:23Dr. Sarah Stombaugh: Now, certainly other things in our life can also contribute to weight gain and people may be experiencing that alongside of their perimenopausal journey with decreasing estrogen, but about a pound and a half per year, specifically due to that hormonal decline.
- 17:39Dr. Sarah Stombaugh: Now, there are some clinical trials with hormone replacement and weight.
- 17:44Dr. Sarah Stombaugh: There was one called the PEPI trial, P-E-P-I the postmenopausal estrogen and progesterone intervention.
- 17:52Dr. Sarah Stombaugh: And this was a randomized placebo controlled trial about 875 women over three years.
- 17:58Dr. Sarah Stombaugh: And what they did is looked at women who were taking estrogen now with or without progesterone compared to women who were taking placebo.
- 18:06Dr. Sarah Stombaugh: So women taking hormones versus women who were taking a placebo and the women who were on hormones gained one kilogram less weight and had 1.2 centimeters less waist circumference compared to the placebo group.
- 18:22Dr. Sarah Stombaugh: So we're not talking huge numbers here, but this is just that hormonal piece alone.
- 18:26Dr. Sarah Stombaugh: There's also been body composition trials where we've seen that patients taking estrogen plus or minus progestin therapy may help to mitigate fat gain and help to preserve lean muscle mass.
- 18:39Dr. Sarah Stombaugh: And so hormone replacement may slow weight gain, even if it doesn't cause weight loss, especially that weight gain around the abdomen.
- 18:48Dr. Sarah Stombaugh: And that's where we're talking about that visceral adiposity, that tissue in and around our organs that is particularly dangerous.
- 18:55Dr. Sarah Stombaugh: Now, one of the questions we get all the time, especially as we're looking at the role of estrogen and metabolic disease, is as we're seeing new medications that come on the market that can be supportive of metabolic disease, things like the GLPs, medications like Ozempic, Wolgovi, Zepound, How can we use these medications and should we use these medications in combination with something like hormone replacement therapy to help support the weight and metabolic goals of postmenopausal patients?
- 19:27Dr. Sarah Stombaugh: So There was a retrospective clinical trial recognizing, and trial is probably the wrong word, but a retrospective study that looked at about 100 postmenopausal patients who were on semaglutide.
- 19:41Dr. Sarah Stombaugh: So that is the generic name for Ozempic and Wagovi.
- 19:44Dr. Sarah Stombaugh: And they looked at the patients who were on semaglutide and also taking hormone replacement therapy versus the women who were taking semaglutide and were not on hormone replacement therapy.
- 19:55Dr. Sarah Stombaugh: And over the course of a year, the patients taking both hormone replacement therapy and semaglutide lost an average of 16% total body weight over that year compared to women taking just the semaglutide alone.
- 20:09Dr. Sarah Stombaugh: No hormone replacement therapy had a 12% weight loss.
- 20:13Dr. Sarah Stombaugh: So 16% with hormone replacement therapy, 12% without hormone replacement therapy.
- 20:18Dr. Sarah Stombaugh: And the hormone replacement therapy users also had a greater improvement in their cardiometabolic markers.
- 20:24Dr. Sarah Stombaugh: So those are things like blood pressure and cholesterol.
- 20:27Dr. Sarah Stombaugh: Now they also That retrospective study was done at Mayo Clinic.
- 20:33Dr. Sarah Stombaugh: They also had a recent presentation where they looked at terzapatide in patients who were and were not using hormone replacement therapy, terzapatide being the same medication, the generic name for Zepound and Monjaro, showing a 17% weight loss in patients with hormone replacement therapy versus 14% weight loss in patients not using hormone replacement therapy.
- 20:56Dr. Sarah Stombaugh: And what is interesting was that in this trial, the women who are using hormone replacement therapy, at least half of those patients with hormone replacement therapy and terzapatide actually lost 20% or greater of their total body weight loss.
- 21:10Dr. Sarah Stombaugh: And so these studies are suggesting that hormone replacement therapy may enhance the response to anti-obesity medications like semaglutide and terzapatide.
- 21:21Dr. Sarah Stombaugh: And this isn't totally surprising when we look at the effect of estradiol.
- 21:26Dr. Sarah Stombaugh: We know that, as I said, there are 37 more than 3,600 receptors for estrogen in the human body.
- 21:34Dr. Sarah Stombaugh: And many of those are involved in things like hunger, like appetite regulation.
- 21:40Dr. Sarah Stombaugh: We think about hunger, we think about fullness.
- 21:42Dr. Sarah Stombaugh: There are a lot of different neuro and hormonal signaling that go into what and how we experience hormonal or how we experience hunger and fullness.
- 21:52Dr. Sarah Stombaugh: Interestingly, we think of hunger and fullness as the same pathway, but there's actually sort of two parallel pathways that run in the brain.
- 22:00Dr. Sarah Stombaugh: One that is stimulating hunger and says, okay, now it's time for me to eat.
- 22:05Dr. Sarah Stombaugh: I'm hungry.
- 22:05Dr. Sarah Stombaugh: I'm ready to eat.
- 22:06Dr. Sarah Stombaugh: Cravings can be associated with that pathway as well.
- 22:10Dr. Sarah Stombaugh: And then there's a pathway that signals satiety.
- 22:13Dr. Sarah Stombaugh: Okay, I'm full.
- 22:14Dr. Sarah Stombaugh: I'm I should stop eating.
- 22:15Dr. Sarah Stombaugh: I should end my meal.
- 22:16Dr. Sarah Stombaugh: And we know that estrogen plays a role in both of these in terms of decreasing ghrelin, which is one of our hunger hormones that makes us feel more hungry, in terms of decreasing leptin or improving leptin sensitivity.
- 22:30Dr. Sarah Stombaugh: Leptin is a hormone that helps our body to recognize fullness.
- 22:34Dr. Sarah Stombaugh: And so many people with obesity, interestingly, actually have elevated leptin levels who would think they would experience fullness more rapidly, but have leptin resistance.
- 22:45Dr. Sarah Stombaugh: So similar to how we talk about insulin resistance, leptin resistance being a condition where you have adequate or even surplus of leptin levels, but your body stops, sort of ignores the signal because there's so much of it.
- 22:57Dr. Sarah Stombaugh: And so estradiol works in that pathway and can help improve leptin sensitivity.
- 23:02Dr. Sarah Stombaugh: So it's very common in the perimenopausal and postmenopausal years that appetite regulation, both at hormone or both at hunger and fullness pieces may be off.
- 23:12Dr. Sarah Stombaugh: And we know that estrogen plays a role in that.
- 23:14Dr. Sarah Stombaugh: in the way that GLP certainly does as well.
- 23:17Dr. Sarah Stombaugh: There's also estrogen receptors in our gastrointestinal system and may help to potentiate the effects of GLP in the system, both in terms of stimulating the receptor, helping to keep it active more longer.
- 23:30Dr. Sarah Stombaugh: And so there's some belief that there's a actually synergistic effect between hormone replacement therapy and GLP medications.
- 23:38Dr. Sarah Stombaugh: And so we've started using, and sort of as a community, we've seen more use in this space.
- 23:44Dr. Sarah Stombaugh: I think one of the biggest things to caution, though, is that this is pretty preliminary data.
- 23:51Dr. Sarah Stombaugh: As we talked about that pendulum swinging of nobody takes hormones to now there's lots of people interested in it.
- 23:57Dr. Sarah Stombaugh: I think we do want to be really careful of how we are really intentionally approaching this.
- 24:03Dr. Sarah Stombaugh: Both for physicians, you have someone who is experienced in this area, someone who has studied in this area, looking for a menopause certified provider may be one of the best options to find someone who is skilled, trained, and tested in perimenopausal symptom management.
- 24:22Dr. Sarah Stombaugh: Additionally, though, looking for people who are board certified in obesity medicine, that skill set certainly really important as well, because we're talking about these two things in combination with one another.
- 24:33Dr. Sarah Stombaugh: Now, the thing that really challenging is that hormone replacement therapy is not approved for weight loss.
- 24:41Dr. Sarah Stombaugh: So when we look at FDA approvals of medication, it is very common that medications will have approvals for very certain indications and then other uses are off-label.
- 24:53Dr. Sarah Stombaugh: So the FDA will say, yes, it's been studied for this indication and it's appropriate to use in that.
- 24:58Dr. Sarah Stombaugh: That being said, we as clinicians use off-label medications all of the time.
- 25:04Dr. Sarah Stombaugh: It is very very common that we'll prescribe medications that were initially thought of maybe for the treatment of depression.
- 25:10Dr. Sarah Stombaugh: We'll use it for appetite suppression or smoking cessation.
- 25:14Dr. Sarah Stombaugh: Medications that were for seizure prevention now are used for migraine prevention.
- 25:19Dr. Sarah Stombaugh: Medications that are for seizures may be used for pain relief.
- 25:22Dr. Sarah Stombaugh: And so we see this happen very frequently where medications are used off-label.
- 25:27Dr. Sarah Stombaugh: So off-label is not a bad thing.
- 25:30Dr. Sarah Stombaugh: but off-label sometimes will draw a little bit more skepticism from people.
- 25:36Dr. Sarah Stombaugh: And it certainly needs to be done judiciously when we recognize, are you an appropriate candidate for this medication?
- 25:43Dr. Sarah Stombaugh: Is it being done in a way that makes sense?
- 25:45Dr. Sarah Stombaugh: Certainly you don't want to just take any medication for any indication.
- 25:49Dr. Sarah Stombaugh: You want to know that there is some data, both in terms of safety, as well as in terms of efficacy or meaning, does that actually work?
- 25:56Dr. Sarah Stombaugh: And so HRT, hormone replacement therapy with estrogen is FDA approved for a few specific.
- 26:05Dr. Sarah Stombaugh: reasons.
- 26:07Dr. Sarah Stombaugh: Specifically, when we think about the postmenopausal years, it does have FDA approval for vasomotor symptoms.
- 26:13Dr. Sarah Stombaugh: So that is the classic menopausal hot flushes or hot flashes and does have FDA approval for that indication.
- 26:20Dr. Sarah Stombaugh: It's also approved for the prevention of osteoporosis.
- 26:24Dr. Sarah Stombaugh: And finally, in the menopausal patient population, also for vulvovaginal atrophy, which is the vaginal dryness that can happen in the postmenopausal years, increasing pain with intercourse, as well as increasing the risk for urinary tract infection.
- 26:40Dr. Sarah Stombaugh: So estrogen is approved for those indications.
- 26:43Dr. Sarah Stombaugh: It does also have other indications for a younger patient population.
- 26:47Dr. Sarah Stombaugh: So people with hypogonadism, meaning that their ovaries aren't functioning properly, that their ovaries aren't producing the estrogen that they should be, or for women who've had total hysterectomy, including ovarian removal, which would decrease their estrogen levels, that it is approved in that patient population as well.
- 27:08Dr. Sarah Stombaugh: So what you did not hear me saying is this medication approved for the use of weight.
- 27:13Dr. Sarah Stombaugh: And so it is not at this time.
- 27:16Dr. Sarah Stombaugh: There certainly are some downsides and some risk of using estrogen medication.
- 27:21Dr. Sarah Stombaugh: So it's important to know What are your individual risk?
- 27:25Dr. Sarah Stombaugh: Again, the book Estrogen Matters can be a really great resource.
- 27:29Dr. Sarah Stombaugh: Dr.
- 27:29Dr. Sarah Stombaugh: Rachel Rubin's podcast on Peter Tia, a great resource.
- 27:32Dr. Sarah Stombaugh: As I'm saying all this thinking, okay, definitely we need an episode talking about the safety and some of the data on these medications.
- 27:39Dr. Sarah Stombaugh: But risk versus benefits.
- 27:42Dr. Sarah Stombaugh: Are there any potential risk or downsides or things that you are uniquely at risk for with using these medications?
- 27:50Dr. Sarah Stombaugh: What are the things that you're at risk for for not using these medications?
- 27:54Dr. Sarah Stombaugh: How long has passed since you've gone through menopause?
- 27:58Dr. Sarah Stombaugh: We know that the longer period of time since you've gone through menopause, there may be less benefit from using these medications compared to people who've had similar estrogen levels or at least continual estrogen stimulation even beyond their perimenopausal years.
- 28:15Dr. Sarah Stombaugh: And so it's challenging because there's not FDA approval from a weight reduction purpose.
- 28:20Dr. Sarah Stombaugh: And I don't know that right now we really have the data for there to be.
- 28:24Dr. Sarah Stombaugh: But what we do know is that estrogen signals in many of these pathways related to our metabolic health.
- 28:30Dr. Sarah Stombaugh: We have some of the early data to show that estrogen in combination with GLP may be really helpful in from a weight perspective that continuing to stimulate estrogen may help not just to decrease weight, but to decrease that central adiposity, that visceral weight gain that can really increase the risk of cardiovascular disease.
- 28:52Dr. Sarah Stombaugh: And so thinking about hormone replacement therapy may be a part of the picture for the right person.
- 28:59Dr. Sarah Stombaugh: Now, as we're wrapping up this episode, like I said, I'm realizing I am leaving a couple of things hanging.
- 29:05Dr. Sarah Stombaugh: And so if you're thinking about oh my gosh, what happens next?
- 29:09Dr. Sarah Stombaugh: If you have been struggling with your weight, there's nothing better I could recommend than to connect with a board certified obesity medicine physician.
- 29:16Dr. Sarah Stombaugh: You can do that at the ABOM, the American Board of Obesity Medicine.
- 29:20Dr. Sarah Stombaugh: Look at a physician and providers who are certified in your area.
- 29:24Dr. Sarah Stombaugh: Similarly, we mentioned the North American Menopause Society, which has recently changed their name to the Menopause Society, but looking at women or physicians rather who are certified in treatment of menopause, that can be really valuable to make sure that you're finding someone who is going to understand these pieces.
- 29:44Dr. Sarah Stombaugh: There are physicians who are certified in both of those things who may be able to help you uniquely navigate the perimenopausal and postmenopausal weight gain.
- 29:53Dr. Sarah Stombaugh: And then as a patient, or even as providers who aren't yet well educated in this field, and I don't say that in a derogatory way, but in a way that even as a physician, Thank you so much for joining us.
- 30:30Dr. Sarah Stombaugh: The residents at your program need to know this because she had felt ill-equipped to be able to do that.
- 30:42Dr. Sarah Stombaugh: And this is as a family medicine physician.
- 30:44Dr. Sarah Stombaugh: So someone who was trained in primary care in the family medicine space, there's a really big emphasis on women's health.
- 30:51Dr. Sarah Stombaugh: And this is not something that because there was so much controversy afterwards.
- 30:56Dr. Sarah Stombaugh: controversy after the Women's Health Initiative, there is a whole cohort of women who are not treated and a cohort of physicians who have not been fully educated on this.
- 31:08Dr. Sarah Stombaugh: And so my best advice for you is to start educating yourself, look at some of those resources to help understand what would this mean for me.
- 31:17Dr. Sarah Stombaugh: And it may be appropriate to use hormone replacement therapy as part of your journey, depending on your symptoms.
- 31:24Dr. Sarah Stombaugh: If you are in Charlotte's Virginia.
- 31:26Dr. Sarah Stombaugh: We are enrolling patients for in-person care.
- 31:29Dr. Sarah Stombaugh: I also see patients throughout the states of Illinois, Tennessee, and Virginia.
- 31:33Dr. Sarah Stombaugh: You can learn more about me at www.sarahstombaumd.com.
- 31:38Dr. Sarah Stombaugh: Thank you so much for joining me today.
- 31:40Dr. Sarah Stombaugh: We'll look forward to seeing you all next week.
- 31:42Dr. Sarah Stombaugh: Bye-bye.